Spironolactone to Decrease Potassium Wasting in Hypercalciurics on Thiazides Diuretics
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
Kidney stone formation due to an excess of calcium in the urine is a common problem. It is
treated with thiazide diuretics. These drugs often cause excessively low blood potassium
levels that in turn require large doses of potassium supplements. These supplements are often
large, unpleasant and easy to forget. We are trying the addition of spironolactone to these
patients' medications to see if it allows them to take a lower dose of potassium.